Bial (Portela e Cª, S.A.) is a pharmaceutical company headquartered in S. Mamede do Coronado, in Trofa, Porto district, Portugal. It was founded in 1924, being among the largest companies of its kind in Portugal.
Bial is today an International Pharmaceutical Group. Its products are to be found in pharmacies in more than 40 countries in 4 continents: Europe, America, Africa and Asia. Some of the group companies are: Laboratórios Bial, Medibial, Bialfar, Bialport, Bial Aristegui, Medimport and Medangol.
Research and products
In 2008, Bial completed clinical evaluation of BIA 2-093 (Eslicarbazepine acetate), a new drug for the adjunctive use in partial seizures in adults with epilepsy. It is marketed as Zebinix or Exalief in Europe and as Aptiom in America.